Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Long-Term Deferred Tax (2023 - 2025)

Invivyd's (IVVD) quarterly Long-Term Deferred Tax came in at $253.0 million in Q4 2025, up 3.27% on a YoY basis from $244.9 million in Q4 2024, and up 3.27% quarter-over-quarter from $244.9 million in Q4 2024.

Analysis

Invivyd (IVVD) Long-Term Deferred Tax (2023 - 2025) Analysis & Trends

Invivyd (IVVD) has reported Long-Term Deferred Tax for 3 consecutive years, with $253.0 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Deferred Tax rose 3.27% year-over-year to $253.0 million; the trailing twelve-month figure through Dec 2025 stood at $253.0 million (up 3.27% YoY), and the FY2025 full-year result was $253.0 million, up 3.27% from the prior year.
  • Long-Term Deferred Tax improved to $253.0 million in Q4 2025 per IVVD's latest filing, from $244.9 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $253.0 million in Q4 2025 and bottomed at $201.1 million in Q4 2023.
  • Historically, Long-Term Deferred Tax has averaged $233.0 million across 3 years, with a median of $244.9 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Long-Term Deferred Tax increased 21.81% in 2024, then rose 3.27% in 2025.
  • Over 3 years, Long-Term Deferred Tax stood at $201.1 million in 2023, then climbed by 21.81% to $244.9 million in 2024, then grew by 3.27% to $253.0 million in 2025.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $253.0 million, $244.9 million, and $201.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 252.95 Mn
Dec 31, 2024 244.95 Mn
Dec 31, 2023 201.08 Mn